TrialBlood2016

Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.